Coston McIsaac & Partners’s Elevance Health ELV Stock Holding History

Coston McIsaac & Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58K	Hold	150	–	–	0.01%	316
2026 Q1	$43K	Hold	150	–	–	0.01%	343
2025 Q4	$52K	Hold	150	–	–	0.01%	310
2025 Q3	$48K	Hold	150	–	–	0.01%	316
2025 Q2	$58K	Hold	150	–	–	0.02%	276
2025 Q1	$65K	Hold	150	–	–	0.02%	238
2024 Q4	$55K	Hold	150	–	–	0.02%	262
2024 Q3	$78K	Hold	150	–	–	0.02%	218
2024 Q2	$81K	Hold	150	–	–	0.03%	201
2024 Q1	$77K	Hold	150	–	–	0.02%	209
2023 Q4	$70K	Hold	150	–	–	0.02%	211
2023 Q3	$65K	Hold	150	–	–	0.02%	212
2023 Q2	$66K	Hold	150	–	–	0.02%	223
2023 Q1	$68K	Hold	150	–	–	0.03%	224
2022 Q4	$76K	Hold	150	–	–	0.03%	204
2022 Q3	$68K	Hold	150	–	–	0.03%	178
2022 Q2	$72K	Buy	+150	New	+$74.2K	0.04%	111

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Coston McIsaac & Partners's ELV Position: Q2 2026 in Review

Coston McIsaac & Partners held its Elevance Health (ELV) position steady in Q2 2026 at 150 shares worth $58K. The position accounts for 0.01% of the portfolio, ranked #316.

Coston McIsaac & Partners first reported a position in ELV in Q2 2022 and has held it in 17 quarters since. The position peaked at $81K in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Coston McIsaac & Partners held 150 shares of Elevance Health worth $58K as of Q2 2026.
Coston McIsaac & Partners left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #316 holding.
Coston McIsaac & Partners first reported a position in Elevance Health in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Elevance Health position peaked at $81K in Q2 2024.
1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.